$ELOX Eloxx Pharmaceuticals, Inc. Insider Trading Week 46/2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Eloxx Pharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Eloxx Pharmaceuticals, Inc. in week 46/2014.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Nov 20 2014 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Option Exercise | A | 0.83 | 3,462 | 2,873 | 67,569 | |
Nov 20 2014 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Option Exercise | A | 0.83 | 27,882 | 23,142 | 64,107 | |
Nov 20 2014 | SVON | Sevion Therapeutic ... | THOMPSON JOHN PHD | Scientific Founder | Option Exercise | A | 0.83 | 34,020 | 28,237 | 53,391 | |
Nov 20 2014 | SVON | Sevion Therapeutic ... | SMIDER VAUGHN | Chief Scientific Of ... | Option Exercise | A | 0.83 | 42,210 | 35,034 | 42,210 | |
Nov 20 2014 | SVON | Sevion Therapeutic ... | MARTELL RON | Chief Executive Off ... | Option Exercise | A | 0.83 | 56,364 | 46,782 | 456,364 | |
Nov 20 2014 | SVON | Sevion Therapeutic ... | Waksal Harlan | Director | Option Exercise | A | 0.83 | 17,168 | 14,249 | 109,500 | |
Nov 20 2014 | SVON | Sevion Therapeutic ... | Waksal Harlan | Director | Option Exercise | A | 0.83 | 38,034 | 31,568 | 92,332 | |
Nov 20 2014 | SVON | Sevion Therapeutic ... | Browne Leslie J | President | Option Exercise | A | 0.83 | 42,210 | 35,034 | 82,065 | |
Nov 20 2014 | SVON | Sevion Therapeutic ... | Rubin Steven D | Director | Option Exercise | A | 0.83 | 3,314 | 2,751 | 28,658 | |
Nov 20 2014 | SVON | Sevion Therapeutic ... | Rubin Steven D | Director | Option Exercise | A | 0.83 | 25,344 | 21,036 | 25,344 | |
Nov 20 2014 | SVON | Sevion Therapeutic ... | RECTOR DAVID | Director | Option Exercise | A | 0.83 | 5,270 | 4,374 | 78,650 | |
Nov 20 2014 | SVON | Sevion Therapeutic ... | RECTOR DAVID | Director | Option Exercise | A | 0.83 | 31,698 | 26,309 | 73,380 | |
Nov 20 2014 | SVON | Sevion Therapeutic ... | FROST PHILLIP MD ET AL | Director | Option Exercise | A | 0.83 | 25,344 | 21,036 | 25,344 | |
Nov 20 2014 | SVON | Sevion Therapeutic ... | Dondero Richard S | VP - Preclinical Re ... | Option Exercise | A | 0.83 | 28,140 | 23,356 | 49,476 | |
Nov 20 2014 | SVON | Sevion Therapeutic ... | RIOS MIGUEL DE LOS | VP - Research | Option Exercise | A | 0.83 | 34,020 | 28,237 | 147,102 | |
Nov 20 2014 | SVON | Sevion Therapeutic ... | GRAZIANO JAMES JOSEPH | Chief Technology Of ... | Option Exercise | A | 0.83 | 28,140 | 23,356 | 28,140 | |
Nov 20 2014 | SVON | Sevion Therapeutic ... | BROOKS JOEL | Chief Financial Off ... | Option Exercise | A | 0.83 | 28,140 | 23,356 | 47,300 | |
Nov 20 2014 | SVON | Sevion Therapeutic ... | BRACA JOHN N | Director | Option Exercise | A | 0.83 | 5,270 | 4,374 | 77,914 | |
Nov 20 2014 | SVON | Sevion Therapeutic ... | BRACA JOHN N | Director | Option Exercise | A | 0.83 | 31,698 | 26,309 | 72,644 |